Biological properties of the antagonist SRI 63-441 in the PAF and endotoxin models of hypotension in the rat and dog

D A HandleyR N Saunders


Intravenous administration of platelet-activating factor (PAF) produces dose-dependent hypotension in several species. We have evaluated a recently developed PAF antagonist, SRI 63-441, for its ability to inhibit the hypotensive effect of PAF in the rat and dog. In the rat, 100 ng/kg PAF produced a 38.6 +/- 5.1% decrease in carotid mean arterial pressure (MAP), followed by a 3.2 +/- 0.7 min recovery period for MAP to return to baseline values. SRI 63-441 reduced the hypotension response in the rat, where the ED50 values for inhibition of MAP were 0.16 mg/kg i.v. and 0.19 mg/kg i.v. for the recovery period. Dogs challenged with 1.5 micrograms/kg PAF i.v. demonstrated a 52 +/- 8% decrease in MAP that persisted for at least 15 min. The ED50 for inhibition of MAP by SRI 63-441 was 0.20 mg/kg i.v. Following injection of tritium-labeled SRI 63-441, 56.8 +/- 2.4% of the dose was recovered in the urine and 43.2 +/- 8.9% in the feces in the rats while in dogs 38.7 +/- 5.6% and 60.9 +/- 23.5% of the dose was excreted in the urine and feces, respectively. In the rat model of endotoxin-induced hypotension, SRI 63-441 given 1 min after a 5 mg/kg endotoxin challenge (which produced a 52 +/- 7% decrease in MAP), reversed the systemic effects,...Continue Reading


Jun 28, 1979·Nature·M ChignardJ Benveniste
Oct 29, 1979·Biochemical and Biophysical Research Communications·M L BlankE E Muirhead
Jan 1, 1986·International Archives of Allergy and Applied Immunology·R PattersonW J Houlihan
Feb 1, 1985·Immunopharmacology·P IñarreaM Sánchez-Crespo
Feb 26, 1985·European Journal of Pharmacology·Z TerashitaS Sumida
Apr 25, 1983·Life Sciences·Z TerashitaK Nishikawa
Oct 15, 1984·European Journal of Pharmacology·P IñarreaM S Crespo
Jan 21, 1983·European Journal of Pharmacology·P BessinJ Benveniste


Dec 1, 1991·Lipids·R RabinoviciG Feuerstein
Aug 20, 1991·Biochimica Et Biophysica Acta·J Lamotte-BrasseurJ J Godfroid
Sep 23, 1987·European Journal of Pharmacology·D A HandleyR N Saunders
Jan 1, 1988·Molecular Aspects of Medicine·N C OlsonC E McCall
Jan 1, 1991·Annals of the New York Academy of Sciences·R D Krell, M McCarthy
Jul 15, 1988·Biochemical and Biophysical Research Communications·R M Rubin, J T Rosenbaum

Related Concepts

Sandoz 63-441
Diastolic Blood Pressure
Canis familiaris
Platelet Activating Factor
Quinolinium Compounds
August Rats
Rats, Laboratory

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Lipidomics & Rhinovirus Infection

Lipidomics can be used to examine the lipid species involved with pathogenic conditions, such as viral associated inflammation. Discovered the latest research on Lipidomics & Rhinovirus Infection.

Alzheimer's Disease: MS4A

Variants within the membrane-spanning 4-domains subfamily A (MS4A) gene cluster have recently been implicated in Alzheimer's disease in genome-wide association studies. Here is the latest research on Alzheimer's disease and MS4A.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Torsion Dystonia

Torsion dystonia is a movement disorder characterized by loss of control of voluntary movements appearing as sustained muscle contractions and/or abnormal postures. Here is the latest research.

Generating Insulin-Secreting Cells

Reprogramming cells or using induced pluripotent stem cells to generate insulin-secreting cells has significant therapeutic implications for diabetics. Here is the latest research on generation of insulin-secreting cells.

Central Pontine Myelinolysis

Central Pontine Myelinolysis is a neurologic disorder caused most frequently by rapid correction of hyponatremia and is characterized by demyelination that affects the central portion of the base of the pons. Here is the latest research on this disease.

Epigenome Editing

Epigenome editing is the directed modification of epigenetic marks on chromatin at specified loci. This tool has many applications in research as well as in the clinic. Find the latest research on epigenome editing here.